Amgen saw the highest growth of 106% in patent filings and 125% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 106% and grants by 125%. GlobalData’s DataBook provides a comprehensive analysis of Amgen‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Amgen has been focused on protecting inventions in United States(US) with one publication in Q4 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly . The United States(US) patent Office are among the top ten patent offices where Amgen is filings its patents. Among the top granted patent authorities, Amgen has 100% of its grants in United States(US)

Pfizer could be the strongest competitor for Amgen

In terms of grant share, Amgen stands in fifth position among its competitors. Amgen and Pfizer secured the top positions according to recent patent publication data.

Drug delivery devices related patents lead Amgen portfolio followed by packaging, and pancreatic cancer

Amgen has highest number of patents in drug delivery devices followed by packaging, pancreatic cancer, leukemia, and osteoporosis. For drug delivery devices, nearly 6% of patents were filed and 5% of patents were granted in Q4 2023.

For comprehensive analysis of Amgen's filings and grants, buy the databook here.

This content was updated on 15 April 2024

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.